QVR’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,400
Closed -$718K 69
2022
Q4
$718K Sell
1,400
-5,600
-80% -$2.84M 0.08% 26
2022
Q3
$3.18M Buy
7,000
+4,000
+133% +$1.91M 0.26% 69
2022
Q2
$1.45M Sell
3,000
-3,700
-55% -$1.83M 0.11% 132
2022
Q1
$3.29M Buy
+6,700
New +$3.06M 0.13% 160
2021
Q4
Sell
-3,900
Closed -$1.45M 120
2021
Q3
$1.45M Buy
3,900
+2,300
+144% +$874K 0.09% 163
2021
Q2
$610K Buy
1,600
+1,000
+167% +$382K 0.06% 160
2021
Q1
$216K Buy
+600
New +$193K 0.02% 125

Other funds holding ELV

QVR's ELV Position: Q2 2024 in Review

QVR sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 444 shares — an estimated $230K sold.

QVR first reported a position in ELV in Q3 2021 and held it in 4 quarters. The position peaked at $1.05M in Q3 2022. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • QVR reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • QVR sold 444 Elevance Health shares in Q2 2024, an estimated $230K.
  • QVR first reported a position in Elevance Health in Q3 2021 and held it in 4 quarters.
  • QVR's Elevance Health position peaked at $1.05M in Q3 2022.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on QVR's 13F filing for Q2 2024, filed 29 Jul 2024.